Skip to main content
HR 6925 116th Congress House

Medical Innovation Acceleration Act of 2020

Official title: To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.

Introduced: May 19, 2020 Introduced by: Biggs, Andy Republican · Arizona See on congress.gov
Health Administrative remediesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 19, 2020
Referred to the House Committee on Energy and Commerce.
May 19, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 19, 2020

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Medical Innovation Acceleration Act of 2020

This bill exempts non-invasive diagnostic devices from the regulatory authority of the Food and Drug Administration.

The bill defines non-invasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6925: Medical Innovation Acceleration Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6925/
MLA
"H.R. 6925: Medical Innovation Acceleration Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6925/.
Bluebook (legal)
H.R. 6925, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6925/.
Markdown link
[H.R. 6925: Medical Innovation Acceleration Act of 2020](https://openamerica.io/bill/116-HR-6925/)
Report a problem